Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 49   

Articles published

SKBI 4.20 -0.13 (-3.00%)
price chart
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
Skystar Bio-Pharmaceutical Company, through its subsidiaries, engages in the research, development, production, marketing, and sale of veterinary healthcare and medical care products in the People's Republic of China.
Related articles »  
Update: Skystar Bio-Pharmaceutical Company Q3 Earnings - Key Developments ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) reported double-digit increases for both revenue and net income for Q3. Revenue increased 14.8% to $18.4 million, while net income increased 32% to $4.9 million or $0.57 per fully diluted share.
Related articles »  
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Related articles »  
Skystar Bio-Pharmaceutical Company Discloses Insider Trading
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), Gregory John M, 10% Owner of Skystar Bio-Pharmaceutical Co had purchased 103,016 shares on December 10, 2014 in a transaction.
Pre-Market Alerts: Skystar Bio Pharmaceutical Company (SKBI), Premier ...  WallStreet Scope
Investor Alert on Insider Trading: Skystar Bio-Pharmaceutical Company ...  Wall Street Pulse
Related articles »  
Short Interest of Skystar Bio-Pharmaceutical Company Drops by -4.2%
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) encountered a drop of 4.2% or -3,713 shares in the short positions. The number dropped from 88,025 on December 15,2014 to 84,312 on December 31,2014.
Skystar Bio-pharmaceutical Co Files SEC Form SC 13G, Statement of ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Stocks Underperform for the Week: Premier Exhibitions Inc , Skystar Bio ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has lost 4.67% during the past week and dropped 3.6% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 6.17%.
Skystar Bio-Pharmaceutical Company major shareholder Purchases $469753 in ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 103,016 shares of Skystar Bio-Pharmaceutical Company stock on the open market in a transaction dated ...
Related articles »  
Thursday Eye-Catching Stocks: Skystar Bio Pharmaceutical Company (SKBI ...
Skystar Bio Pharmaceutical Company (SKBI) closed the day Wednesday at $4.39, a loss of -0.90% after trading at a volume of 8,497 shares.
Insider Buying: John M. Gregory Buys 70800 Shares of Skystar Bio ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 70,800 shares of the stock in a transaction that occurred on Tuesday, December 23rd.
Related articles »